graduate at Farmacia e Bioquimica from Universidade Federal do Rio Grande do Sul (1975), master's at Imunologia from Universidade Federal do Rio de Janeiro (1985) and ph.d. at Imunologia from Universidade Federal do Rio de Janeiro (1992). Has experience in Immunology, focusing on Celular Imunology, acting on the following subjects: imunologia, citocinas, paracoccidioides brasiliensis, tuberculose and dna-hsp65. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Multiple sclerosis is an autoimmune disease that affects the central nervous system (CNS) and has no cure yet. Recently, there have been major advances in the development of disease-modifying treatments and these new approaches include dietary factors. Evidences observed in patients and in experimental models indicate that fungal derivatives and vitamin A can contribute to the improvement…
Multiple sclerosis (MS) is a progressive inflammatory disease that damages the central nervous system (CNS). The currently available therapies for MS are primarily focused in minimizing the progression of disability and reducing the number of relapses, therefore new prophylactic and therapeutic strategies for MS are necessary. In this context, the present study was designed to determine i…
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease which affects the joints. Most of current therapies for treating RA and other autoimmune diseases is based on the suppression of immune response in general, which increases susceptibility to infectious agents. The aim of this study is to define an immunomodulatory strategy for prophylaxis and/or therapy of RA. For this…
(Only some records are available in English at this moment)
Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system (CNS).Approximately 85% of patients have relapsing-remitting MS (RRMS) characterized by an initial neurological dysfunction event followed by remission and relapse episodes. Its immunopathogenesis is complex and involves the interplay of distinct autoreactive T cell subsets and innate immune…
Multiple sclerosis (MS) is a chronic and demyelinating disease of the central nervous system (CNS). MS immunophatogenesis involves Th1, Th17 and Tc autoreactive lymphocytes and also macrophages and microglial cells activation that release many pro-inflammatory mediators and free radicals. Current therapies do not determine disease cure and some subjects are refractory to therapies. Theref…
Multiple sclerosis (MS) is a progressive inflammatory disease that damages the central nervous system (CNS). Currently available therapies for MS are primarily focused in minimizing the progression of disability and reducing the number of relapses, therefore, new prophylactic and therapeutic strategies for MS are necessary. Most of the therapeutic strategies to control this disease are di…
(Only some records are available in English at this moment)
| 15 / 7 | Completed research grants |
| 30 / 13 | Completed scholarships in Brazil |
| 1 / 0 | Completed scholarships abroad |
| 46 / 20 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID